Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

TAGO FIFFU-GEN, OROSOMUCOID

K-Number: K841734 · 1984-06-01

ApplicantTago, Inc.
Decision Date1984-06-01
Product CodeLKL
Advisory CommitteeIM
DecisionSubstantially Equivalent

Device Summary

TAGO FIFFU-GEN, OROSOMUCOID is the device name listed in this FDA 510(k) record. The listed applicant is Tago, Inc.. It received FDA 510(k) clearance on 1984-06-01 under 510(k) number K841734. The device is classified under product code LKL. It was reviewed by the IM advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the TAGO FIFFU-GEN, OROSOMUCOID?

TAGO FIFFU-GEN, OROSOMUCOID is a medical device that received FDA 510(k) clearance on 1984-06-01. The listed applicant is Tago, Inc.. The 510(k) number is K841734.

When did TAGO FIFFU-GEN, OROSOMUCOID receive FDA 510(k) clearance?

TAGO FIFFU-GEN, OROSOMUCOID received FDA 510(k) clearance on 1984-06-01, under 510(k) number K841734.

Who is the listed applicant for TAGO FIFFU-GEN, OROSOMUCOID?

The FDA 510(k) record lists Tago, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for TAGO FIFFU-GEN, OROSOMUCOID?

The FDA product code for TAGO FIFFU-GEN, OROSOMUCOID is LKL.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Tago, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K841265TAGO DIFFU-GEN C-REACTIVE PROTEINK834218DIFFU-GEN APOLIPOPROTEIN A-I RADIAL -K840404DIFFU-GEN HAPTOGLOBIN RADIAL IMMUNOK833129TAGO DIFFU-GEN-APOLIPOPROTEIN B-100K830611RA SCREENING TESTK830531MONO SCREENING TEST

View all 8 devices →

Related Devices (Code: LKL)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K993441K-ASSAY ALPHA-1 AGKamiya Biomedical Co.K964299N-ASSAY TIA MULTI V-NLCrestat Diagnostics, Inc.K964257IMMAGE IMMUNOCHEMISTRY SYSTEM ALPHA-1-ACID GLYCOPROTEIN (AAG) REAGENTBeckman Instruments, Inc.K922417AL-ACID GLYCOPROTEIN RID KITThe Binding Site, Ltd.K904175RAICHEM (TM) SPIA (TM) - ACID GLYCOPROTEIN REAGENTReagents Applications, Inc.K884217TECHNICON DPA-1 ANALYTE ALPHA 1 ACID GLYCOPROTEINTechnicon Instruments Corp.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑